Antibiotics are no longer able to treat infections as effectively as they once did because many pathogens have developed ...

India's common infections are becoming untreatable as widely used antibiotics lose efficacy, according to a new ICMR report.

GSK is investing £45m with the Fleming Initiative to launch six research programmes using cutting-edge AI to tackle antimicrobial resistance ...

GSK funding allocated to six new research programmes which will combine expertise and using cutting edge AI technology to accelerate research to tackle antimicrobial resistance (AMR).

Wockhardt shares surge as US FDA accepts first-ever NDA from an Indian pharma company for new antibiotic Zaynich, aimed at ...

Researchers have designed a chemical phototherapy tool that when exposed to blue light damages an enzyme found in ...

Blacksmith Medicines receives European patent for LpxC-targeting antibacterial compounds: San Diego, California Tuesday, November 25, 2025, 16:00 Hrs [IST] Blacksmith Medicines, I ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the European Patent Office has issued a ...

Stool-based tests that combine microbial markers such as Fusobacterium nucleatum, colibactin-positive E. coli and ...

The spread of resistance genes like NDM, OXA-48, and TEM among bacteria is also a significant concern, as it could lead to the emergence of new superbugs. Hence, the ICMR report warns that if ...

Pfizer announced the introduction of a novel treatment in the United Arab Emirates for adult patients with serious Gram-negative bacterial infections in the United Arab Emirates. This milestone marks ...